CannaPharmaRx Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • CPMD
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $0.24
  • (As of Monday Closing)

CannaPharmaRx General Information

Description

Cannapharmarx Inc is involved in the cannabis sector. The company negotiates, acquires, and develops various cannabis cultivation projects throughout Canada. Its three projects include the Hanover Project; the Great Northern Project; and the acquisition of Sunniva Medical.

Contact Information

Website
www.cannapharmarx.com
Formerly Known As
Cavion Technologies
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 888 3rd Street Southwest
  • Suite 3600
  • Calgary, Alberta T2P 5C5
  • Canada
+1 (856) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CannaPharmaRx Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $0.03 - $2.60 $10.3M 42.7M 158K -$0.48

CannaPharmaRx Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 35,847 54,610 30,836
Revenue 0 0 0 0
EBITDA (14,407) (15,849) (954) (7)
Net Income (17,654) (20,451) (3,094) (7)
Total Assets 16,449 16,017 10,098 0
Total Debt 10,305 9,282 9,201 20
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CannaPharmaRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CannaPharmaRx‘s full profile, request access.

Request a free trial

CannaPharmaRx Executive Team (7)

Name Title Board Seat Contact Info
Dominic Colvin Chief Executive Officer & Board Member
Gerry Crocker Chief Executive Officer
John Cassels Chief Financial Officer
Andrew Steedman Chief Operating Officer
You’re viewing 4 of 7 executive team members. Get the full list »

CannaPharmaRx Board Members (1)

Name Representing Role Since
0000000 000000 CannaPharmaRx Chief Executive Officer & Board Member 000 0000
To view CannaPharmaRx’s complete board members history, request access »

CannaPharmaRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CannaPharmaRx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CannaPharmaRx‘s full profile, request access.

Request a free trial

CannaPharmaRx Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 (00, 28-Jan-2021 000000000 00000 00 0000 Buildings and Property 0000000 000000
0000000000000 (000 07-Jan-2021 000000000 00000 00 00.00 Buildings and Property 0000000 000000
0000000000000 (000 07-Jul-2020 000000000 00000 00 0000 Buildings and Property
0000000 (00000000 12-Jun-2019 000000000 00000 00 000.00 Buildings and Property 0000000 000000
GN Ventures 28-Feb-2019 Corporate Pharmaceuticals 0000000 000000
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

CannaPharmaRx Subsidiaries (1)

Company Name Industry Location Founded
00000000000 000000 Cultivation Hanover, Canada
To view CannaPharmaRx’s complete subsidiaries history, request access »